Doctolib
Financials
Estimates*
EUR | 2016 | 2018 | 2022 | 2023 |
---|---|---|---|---|
Revenues | 2.7m | 11.7m | 217m | 300m |
% growth | - | - | - | 38 % |
Profit | - | - | - | (166m) |
% profit margin | - | - | - | (55 %) |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Seed | ||
€1.0m | Seed | ||
€4.0m | Series A | ||
* | €18.0m | Series B | |
* | €26.0m | Series C | |
$42.0m | Late VC | ||
€150m Valuation: €1.0b 85.4x EV/LTM Revenues | Late VC | ||
* | €250m | Debt | |
* | €250m Valuation: €5.8b | Late VC | |
Total Funding | €487m |
Recent News about Doctolib
EditDoctolib is a leading digital healthcare platform that connects patients with healthcare professionals, facilitating easier and faster access to medical services. Operating primarily in France, Germany, and Italy, Doctolib serves a wide range of clients including individual patients, medical practices, and hospitals. The company’s business model revolves around subscription fees paid by healthcare providers for using its software solutions, which include online appointment booking, teleconsultation services, and practice management tools. By improving the daily operations of healthcare personnel and enhancing patient access to healthcare, Doctolib aims to build a more efficient and accessible healthcare system. The platform’s revenue is generated through these subscription services, making it a scalable and sustainable business model.
Keywords: digital healthcare, teleconsultation, appointment booking, practice management, healthcare access, patient services, medical professionals, subscription model, European market, healthcare efficiency.